Pages that link to "Q71988769"
Jump to navigation
Jump to search
The following pages link to Antiischemic effects of nicorandil during coronary angioplasty in humans (Q71988769):
Displaying 12 items.
- Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology (Q33972677) (← links)
- Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects (Q34086056) (← links)
- Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium (Q34805190) (← links)
- Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients (Q35871153) (← links)
- K(ATP) channel therapeutics at the bedside (Q36161668) (← links)
- Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits (Q37019388) (← links)
- Digital assessment of the epicardial electrocardiogram: novel methodology for a core laboratory for clinical studies. (Q39499211) (← links)
- Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes (Q44120533) (← links)
- Nicorandil attenuates the mitochondrial Ca2 overload with accompanying depolarization of the mitochondrial membrane in the heart (Q44699591) (← links)
- Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. (Q46642344) (← links)
- Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels (Q50514129) (← links)
- Potentiating effects of nicorandil on the adenosine A2 receptor‐mediated vasodepression in rats: potential role for KATP channels (Q74495431) (← links)